Proresolution Lipid Mediators in Multiple Sclerosis — Differential, Disease Severity-Dependent Synthesis — A Clinical Pilot Trial

BACKGROUND: The severity and longevity of inflammation is controlled by endogenous counter-regulatory signals. Among them are long-chain polyunsaturated fatty acid (PUFA)-derived lipid mediators, which promote the resolution of inflammation, an active process for returning to tissue homeostasis. OBJ...

Descripción completa

Detalles Bibliográficos
Autores principales: Prüss, Harald, Rosche, Berit, Sullivan, Aaron B., Brommer, Benedikt, Wengert, Oliver, Gronert, Karsten, Schwab, Jan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568070/
https://www.ncbi.nlm.nih.gov/pubmed/23409068
http://dx.doi.org/10.1371/journal.pone.0055859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568070/
https://www.ncbi.nlm.nih.gov/pubmed/23409068
http://dx.doi.org/10.1371/journal.pone.0055859

Ejemplares similares